Need to raise investment or secure grant funding to support development of a new medical technology or service? This course will teach you how to prepare robust funding applications, understand what investors are looking for, develop your pitch deck and help you identify the right funding route for your business or project.
This two hour course will help you make successful funding applications and improve your chances of raising investment from angels and venture capitalists. Join us on 3rd May from 1pm-3pm to discover more.
Topics covered will include:
- Demystifying some of the investment language
- Funding ideas for small businesses and start-ups
- Funding for early, mid and late-stage development
- Examples of grant funding bodies and current opportunities
- Top tips for preparing a robust grant application
- Examples of angel, seed and VC investors
- Fundraising and what investors are looking for
- Pitch fundamentals and developing a pitch deck
- Valuation strategies
WHO WOULD BENEFIT FROM ATTENDING?
Anyone who is involved in developing new healthcare technologies and products, be it as an entrepreneur, clinician, academic or small business, including professionals with an interest in/working in:
- Innovators with an early-stage idea
- Business development
- Product development
- Research & development
- Technology transfer
Industry Fees: £45 +VAT
Public Sector: £25 + VAT
NHS Staff: Free with an NHS email (contact us to secure your place – email@example.com)
Places are limited and allocated on a first-come, first-served basis.
MEET THE SPEAKERS
Dr Anne Blackwood, Chief Executive, Health Tech Enterprise
Anne has over 20 years experience in commercialising life science innovations and a proven track record in raising seed financing and investment for early stage technologies.
Dr Karen Law, Head of Innovation, Health Tech Enterprise
Karen is an experienced IP and commercialisation professional having over 10 years’ experience of leading the identification, evaluation, protection, development, and commercialisation of innovations developed by research scientists and clinicians. She has negotiated numerous licensing agreements for a diverse range of technologies including therapeutics and devices.